From the Blood Research Institute, BloodCenter of Wisconsin, Milwaukee (S.L., M.C.W.); Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville (B.J.Z., K.M., M.V.A., A.V.S.); and Department of Pharmacology and Toxicology (Z.-D.G., J.A.A.), Cardiovascular Center (Z.-D.G., X.Z., J.E.M., D.X.Z., J.A.A.), Department of Medicine (X.Z., J.E.M., D.X.Z.), Department of Physiology (H.L., D.L.M.), and Division of Biostatistics (A.S.), Medical College of Wisconsin, Milwaukee.
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1486-94. doi: 10.1161/ATVBAHA.114.303678. Epub 2014 May 1.
Small GTPase Ras-related protein 1 (Rap1b) controls several basic cellular phenomena, and its deletion in mice leads to several cardiovascular defects, including impaired adhesion of blood cells and defective angiogenesis. We found that Rap1b(-/-) mice develop cardiac hypertrophy and hypertension. Therefore, we examined the function of Rap1b in regulation of blood pressure.
Rap1b(-/-) mice developed cardiac hypertrophy and elevated blood pressure, but maintained a normal heart rate. Correcting elevated blood pressure with losartan, an angiotensin II type 1 receptor antagonist, alleviated cardiac hypertrophy in Rap1b(-/-) mice, suggesting a possibility that cardiac hypertrophy develops secondary to hypertension. The indices of renal function and plasma renin activity were normal in Rap1b(-/-) mice. Ex vivo, we examined whether the effect of Rap1b deletion on smooth muscle-mediated vessel contraction and endothelium-dependent vessel dilation, 2 major mechanisms controlling basal vascular tone, was the basis for the hypertension. We found increased contractility on stimulation with a thromboxane analog or angiotensin II or phenylephrine along with increased inhibitory phosphorylation of myosin phosphatase under basal conditions consistent with elevated basal tone and the observed hypertension. Cyclic adenosine monophosphate-dependent relaxation in response to Rap1 activator, Epac, was decreased in vessels from Rap1b(-/-) mice. Defective endothelial release of dilatory nitric oxide in response to elevated blood flow leads to hypertension. We found that nitric oxide-dependent vasodilation was significantly inhibited in Rap1b-deficient vessels.
This is the first report to indicate that Rap1b in both smooth muscle and endothelium plays a key role in maintaining blood pressure by controlling normal vascular tone.
小分子 GTP 酶 Ras 相关蛋白 1(Rap1b)控制着几种基本的细胞现象,其在小鼠中的缺失导致多种心血管缺陷,包括血细胞黏附受损和血管生成缺陷。我们发现 Rap1b(-/-)小鼠出现心脏肥大和高血压。因此,我们研究了 Rap1b 在调节血压中的功能。
Rap1b(-/-)小鼠出现心脏肥大和血压升高,但心率正常。用血管紧张素 II 型 1 受体拮抗剂氯沙坦纠正血压升高,减轻 Rap1b(-/-)小鼠的心脏肥大,表明心脏肥大可能继发于高血压。Rap1b(-/-)小鼠的肾功能和血浆肾素活性指数正常。在体外,我们检查了 Rap1b 缺失对平滑肌介导的血管收缩和内皮依赖性血管舒张的影响,这是控制基础血管张力的两个主要机制,是否是高血压的基础。我们发现,在基础状态下,刺激血栓素类似物或血管紧张素 II 或苯肾上腺素时,收缩性增加,肌球蛋白磷酸酶的抑制性磷酸化增加,这与基础张力升高和观察到的高血压一致。对 Rap1 激活剂 Epac 的反应中,环磷酸腺苷依赖性松弛在 Rap1b(-/-)小鼠的血管中减少。对血流升高的内皮舒张性一氧化氮的释放缺陷导致高血压。我们发现,在 Rap1 缺乏的血管中,一氧化氮依赖性血管舒张明显受到抑制。
这是第一个报道表明,Rap1b 在平滑肌和内皮中都通过控制正常血管张力在维持血压方面发挥关键作用。